ClearPoint Neuro, Inc.CLPTNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +40.96% | +14.11% | +11.07% | +17.27% | +9.10% |
| Gross Profit Growth | +48.09% | +18.66% | +13.41% | +11.39% | +15.54% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +12.02% | +9.74% | +8.91% | +2.88% | +3.03% |
| Weighted Average Shares Diluted Growth | +12.02% | +9.74% | +8.91% | +2.88% | +3.03% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +59.86% | +46.78% | +16.91% | -5.88% | +3.23% |
| Inventory Growth | -21.45% | -13.25% | -17.31% | -21.64% | -6.74% |
| Asset Growth | -8.31% | -8.14% | -43.94% | +19.58% | +50.17% |
| Book Value per Share Growth | +7.45% | +9.27% | -46.93% | -40.27% | -46.87% |
| Debt Growth | -73.64% | -74.41% | -75.26% | +156.98% | +867.65% |
| R&D Expense Growth | +36.48% | +25.64% | +28.72% | +22.72% | +4.13% |
| SG&A Expenses Growth | +16.77% | +15.94% | +29.11% | +12.11% | +4.77% |